# Posttraumatic Stress Disorder

Diagnose PTSD with a trauma-informed clinical assessment rather than a self-report score alone, then prioritize manualized trauma-focused psychotherapy. Use symptom measures to track change, assess suicide risk directly, and avoid benzodiazepines because they do not treat core PTSD symptoms and may undermine recovery.

**Clinical question:** How should physicians screen, confirm, treat, and monitor posttraumatic stress disorder in adults?

Updated: 2026-09-15T17:40:48.081431+00:00

## What matters in practice
- Use the PC-PTSD-5 as a brief primary-care screen after establishing trauma exposure; a positive screen requires diagnostic assessment rather than automatic diagnosis. [14][15]
- Use the PCL-5 to quantify symptom burden and longitudinal response, but confirm PTSD with a structured clinical assessment when diagnosis will guide treatment or disability decisions. [3][17]
- Offer a manualized trauma-focused psychotherapy—particularly cognitive processing therapy, prolonged exposure, trauma-focused CBT, or EMDR—as the central treatment strategy. [5][18][22]
- Assess suicidal ideation and behavior directly at diagnosis and during treatment; in a large veteran cohort, initiation of CPT or PE was associated with lower suicide risk. [2]
- Avoid benzodiazepines for PTSD: they do not improve core symptoms or PTSD-related sleep dysfunction and are associated with important clinical harms. [12]

## Triage safety and establish whether PTSD is the treatment target

Separate acute safety needs, probable PTSD, and competing psychiatric syndromes before selecting treatment.

At the first PTSD-focused visit, assess current suicidal ideation, suicidal behavior, intent, planning, access to lethal means, and ability to maintain safety. Use a structured instrument such as the Columbia-Suicide Severity Rating Scale when a reproducible suicide-risk assessment is needed. Escalate to urgent psychiatric or emergency evaluation when imminent self-harm risk cannot be managed in the current setting. [12]

Establish trauma exposure before administering symptom screens. The PC-PTSD-5 was designed with a trauma-exposure stem so that patients without reported qualifying exposure do not complete the symptom items; this limits unnecessary screening in the substantial proportion of primary-care patients who are not trauma exposed. [14]

Do not convert a positive screen into a diagnosis without clinical assessment. PTSD diagnosis requires determining whether symptoms meet the DSM-5 cluster pattern, whether symptoms are clinically significant, and whether another condition better explains the presentation. On CAPS-5, individual symptoms are considered present at a severity rating of 2 or greater, and the diagnostic pattern requires at least 1 intrusion symptom, 1 avoidance symptom, 2 negative cognition/mood symptoms, and 2 arousal/reactivity symptoms. [17]
- Prioritize immediate safety planning and level-of-care decisions over routine symptom scoring when the patient reports active suicidal intent or recent suicidal behavior. [12]
- Ask specifically about alcohol and other substance use, depressive symptoms, anxiety symptoms, mania, and somatic concerns because these constructs may overlap with PTSD presentations and affect treatment sequencing. [3][10]
- Document the index trauma or traumas, symptom onset, avoidance patterns, isolation, and trauma-related cognitions; CPT and PE directly target avoidance, isolation, and trauma-linked negative cognitions. [2]

*Assessment tools serve different clinical functions and should not be used interchangeably. [3][13][14][17]*

| Tool | Best clinical use | Actionable interpretation | Key limitation |
| --- | --- | --- | --- |
| PC-PTSD-5 | Brief primary-care case finding after a trauma-exposure stem. [14] | A positive result identifies patients needing fuller PTSD assessment; one public-healthcare study found cut score 1 optimized sensitivity, whereas cut score 4 maximized probable efficiency against self-reported DSM-5 PTSD. [15] | Cut points vary by setting and reference standard; it is not a diagnostic interview. [15] |
| PCL-5 | Self-reported symptom severity and repeated outcome measurement. [13][17] | Published recommended cutoffs span 23-49, most often 31-33; interpret any score in the population and purpose for which it was validated. [13] | Agreement with CAPS-5 is incomplete, including in treatment-seeking military and veteran samples. [17] |
| CAPS-5 or CAPS-5-R | Structured clinician-administered diagnostic confirmation and severity assessment. [3][17] | Rate symptoms on a 0-4 scale; a rating of 2 or higher represents moderate/threshold symptom severity for DSM-5 diagnostic scoring. [17] | Requires trained administration and is less practical for universal primary-care screening. [3][17] |

## Use screening results to trigger assessment and longitudinal measurement

Choose the shortest validated measure that answers the immediate clinical question.

For opportunistic primary-care screening, PC-PTSD-5 is suited to identifying trauma-exposed patients who need follow-up. Its development study reported excellent diagnostic accuracy, with area under the curve greater than 0.92 for the evaluated screen versions in a veteran primary-care sample. Threshold selection should favor sensitivity when the consequence of a missed case is high and diagnostic follow-up is available; higher thresholds trade sensitivity for fewer positive screens. [14][15]

Use the 20-item PCL-5 when the decision is symptom measurement rather than brief case finding. A systematic review found that recommended probable-PTSD cutoffs varied substantially, from 23 to 49, with 31-33 most frequently identified. Therefore, use a locally validated threshold rather than treating a single universal cutoff as diagnostic across veterans, civilians, primary care, and specialty populations. [13]

For treatment follow-up, repeat the same instrument rather than comparing raw scores across different instruments. In a treatment-seeking military and veteran sample, diagnostic agreement between baseline PCL-5 and CAPS-5 was only moderate-to-weak by kappa despite 84.9% overall consistency, reinforcing that symptom change on PCL-5 and diagnostic remission on CAPS-5 answer related but different questions. [17]
- Use CAPS-5 when a clinician-administered diagnosis is needed, including when self-report results conflict with the interview, symptom presentation is diagnostically complex, or a formal diagnostic determination will materially change care. [17]
- Use serial PCL-5 scores to support shared decisions about continuing, adapting, or changing treatment, while reassessing suicidality and functional impairment rather than relying on score change alone. [2][13][17]
- Avoid using a negative or low self-report result to dismiss trauma-related illness when avoidance, shame, dissociation, literacy, cultural factors, or inconsistent reporting is clinically plausible; proceed with clinician assessment when suspicion remains high. [3][17]

## Offer trauma-focused psychotherapy as first-line treatment

Treatment selection should prioritize an evidence-based trauma-focused protocol that the patient can access and engage in.

Offer a manualized trauma-focused psychotherapy to adults with confirmed PTSD unless acute instability prevents outpatient participation. Guideline syntheses consistently identify trauma-focused cognitive behavioral approaches as first-line psychological treatment; named options include cognitive processing therapy (CPT), prolonged exposure (PE), trauma-focused CBT, cognitive therapy, and eye movement desensitization and reprocessing (EMDR). [5][18]

Select CPT when trauma-related beliefs and persistent negative cognitions are prominent treatment targets; select PE when behavioral and cognitive avoidance is central and the patient is willing to engage in systematic exposure-based work. Both CPT and PE target avoidance and isolation and have been associated with reductions in negative cognitions around traumatic memories. [2][5]

Offer EMDR when it is available and acceptable, particularly when patient preference or access favors it over CPT or PE. A systematic overview of meta-analyses found that beneficial effects lasting beyond 1 month after treatment were supported most consistently for trauma-focused CBT interventions and EMDR. [22]

Do not withhold trauma-focused treatment solely because PTSD is accompanied by common comorbid symptoms. Instead, identify the condition that creates an immediate barrier—such as imminent suicide risk, uncontrolled intoxication, severe mood elevation, or inability to participate safely—and stabilize that barrier while maintaining a plan to initiate PTSD-directed psychotherapy. Concern about comorbidity has contributed to debate about parallel treatment models, particularly for co-occurring substance use disorders. [10]
- Discuss the trauma-processing component explicitly before referral; trauma-focused treatment uses cognitive, emotional, or behavioral techniques in which processing traumatic experience is central to therapy. [5]
- If the patient declines trauma-focused therapy, revisit preference, practical barriers, and treatment expectations rather than labeling the disorder treatment resistant after one declined referral. Capacity and therapist availability are documented barriers to CPT and PE reach. [2]
- Use non-trauma-focused psychotherapy only with clarity about the tradeoff: present-centered therapy has been studied, but trauma-focused cognitive behavioral therapies have the broadest empirical support for PTSD and related comorbidities. [5]

### Choosing among evidence-based trauma-focused therapies

No source-supported hierarchy establishes that one of CPT, PE, trauma-focused CBT, or EMDR should be universally preferred. Match the protocol to patient preference, local clinician competence, trauma presentation, and feasibility, while preserving delivery of a structured evidence-based treatment rather than substituting nonspecific supportive counseling. [5][18][22]
- CPT: cognitive processing approach with emphasis on trauma-related beliefs. [2][5]
- PE: exposure-based approach that directly targets avoidance. [2][5]
- EMDR: an evidence-supported trauma-focused option with long-term benefit signal in meta-analytic evidence. [18][22]

*Practical selection of trauma-focused psychotherapy should be preference-sensitive because multiple approaches have evidence of efficacy. [5][18][22]*

| Treatment | Core clinical target | When it is a practical fit |
| --- | --- | --- |
| Cognitive processing therapy | Negative cognitions related to traumatic memories, avoidance, and isolation. [2][5] | Patient can engage in a structured cognitive trauma-processing protocol and prefers this approach. [5] |
| Prolonged exposure | Avoidance of trauma-related cues and experiences. [2][5] | Patient accepts an exposure-based protocol and has sufficient stability for consistent participation. [5] |
| Trauma-focused CBT or cognitive therapy | Cognitive, emotional, and behavioral processing of trauma. [5][18] | A trained clinician and manualized program are locally available. [5][18] |
| EMDR | Trauma processing within an EMDR protocol. [5][18] | Patient preference or local expertise favors EMDR; evidence supports benefit beyond 1 month after treatment. [22] |

## Do not use benzodiazepines as PTSD treatment

Pharmacotherapy should not displace trauma-focused psychotherapy when an evidence-based psychotherapy is available.

Avoid initiating benzodiazepines to treat PTSD, including for PTSD-related anxiety or sleep disturbance. VA guidance recommends avoiding benzodiazepines in patients with PTSD symptoms because they are ineffective for core PTSD symptoms and do not improve PTSD-related sleep dysfunction. [12]

Benzodiazepine exposure carries a clinically important tradeoff in PTSD: reported associations include increased substance use, depression, aggression, greater PTSD severity, and reduced efficacy of trauma-focused psychotherapy. These concerns are especially relevant when a patient is being referred for CPT, PE, or another trauma-focused protocol. [12]

When a patient is already receiving a benzodiazepine, do not abruptly stop it solely because PTSD is diagnosed. Reassess indication, duration, co-occurring substance use, depression, aggression, and readiness for a structured taper; use a benzodiazepine-tapering guideline when risks outweigh benefits. [12]

Nightmares and sleep fragmentation should prompt a targeted evaluation rather than reflexive sedative prescribing. Doxazosin has limited and heterogeneous evidence for trauma-related nightmares, with mixed randomized-trial findings; it may be considered only as an adjunct within a comprehensive treatment plan, not as a replacement for first-line psychotherapy. [21]
- Before adding a sleep-directed medication, document nightmare frequency, insomnia pattern, daytime impairment, substance use, and whether the patient is receiving PTSD-directed psychotherapy. [12][21]
- If considering doxazosin for trauma-related nightmares, discuss uncertain efficacy and monitor adverse effects; optimal dose and duration remain undetermined in the cited review. [21]
- Avoid presenting medication for a single symptom as treatment of PTSD itself when core trauma symptoms remain untreated. [12][21]

## Monitor engagement, symptom trajectory, and suicide risk through treatment

Follow-up should determine whether the patient is receiving an adequate trauma-focused intervention and remains safe enough to continue it.

At each early treatment contact, reassess suicidal ideation, treatment attendance, avoidance-driven disengagement, substance use, and barriers to completing the selected protocol. In a population-based cohort of 847,217 veterans with an initial PTSD diagnosis, initiation of CPT or PE was associated with lower suicide risk after adjustment for measured clinical and demographic characteristics; this supports active efforts to connect eligible patients to these therapies rather than passive referral alone. [2]

Use a consistent symptom measure such as the PCL-5 at clinically meaningful intervals during and after treatment, but interpret improvement alongside functioning and clinician assessment. In one treatment-seeking military and veteran sample, 44.7% achieved CAPS-5 remission after treatment while 48.9% no longer met probable PTSD on PCL-5, illustrating that symptom-screen status and structured-interview remission can diverge. [17]

Escalate the treatment plan when the patient cannot access the selected evidence-based psychotherapy, repeatedly disengages, develops worsening suicidality, or has diagnostic uncertainty despite serial self-report scores. Address modifiable access barriers because therapist capacity, particularly in rural and underresourced settings, can reduce reach of CPT and PE. [2]
- Continue to measure symptoms after treatment completion when relapse, residual symptoms, or functional impairment remain clinically relevant; PCL-5 is used for assessment of treatment effectiveness. [4][13]
- When PCL-5 and interview findings conflict, resolve the discrepancy with clinician-administered assessment rather than changing treatment solely from a screening threshold. [17]
- For patients considering novel interventions such as MDMA-assisted psychotherapy, explain that the relationship of studied protocols to currently recommended trauma-focused psychotherapies remains unclear; do not substitute investigational approaches for established first-line care. [19]

## Common questions

### Can a PCL-5 score diagnose PTSD?

No. PCL-5 is useful for symptom quantification and treatment monitoring, but published probable-PTSD cutoffs range from 23 to 49 and agreement with CAPS-5 is incomplete. Confirm clinically important diagnoses with structured assessment when needed. [13][17]

### Should trauma-focused psychotherapy be deferred until all comorbid symptoms resolve?

Not routinely. Identify and stabilize immediate barriers to safe participation, such as imminent suicide risk or uncontrolled intoxication, while maintaining a plan for PTSD-directed treatment. Comorbidity alone should not default the patient to nonspecific care. [10]

## References
1. Dialectical Behavior Therapy for Posttraumatic Stress Disorder (DBT ... — jamanetwork.com — https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2768029
2. Clinical Implications of Trauma-Focused Therapy for Veterans — jamanetwork.com — https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2828496
3. The revised Clinician‐Administered PTSD scale for DSM‐5 (CAPS‐5‐R): Initial psychometric evaluation in a trauma‐exposed community sample - Jackson - 2025 - Journal of Traumatic Stress - Wiley Online Library — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/10.1002/jts.23093
4. The prevalence of post-traumatic stress disorder (PTSD) in US combat soldiers: a head-to-head comparison of DSM-5 versus DSM-IV-TR symptom criteria with the PTSD checklist - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S2215036614702354
5. Focusing on trauma-focused psychotherapy for posttraumatic stress disorder - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S2352250X16301956
6. Focusing on trauma-focused psychotherapy for posttraumatic stress ... — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S2352250X16301956
7. Eye Movement Desensitization and Reprocessing - an overview — www.sciencedirect.com — https://www.sciencedirect.com/topics/nursing-and-health-professions/eye-movement-desensitization-and-reprocessing
8. [PDF] CG26 Post-traumatic stress disorder (PTSD) - NICE — www.nice.org.uk — https://www.nice.org.uk/guidance/ng116/evidence/full-guideline-pdf-6602623598
9. Overview | Post-traumatic stress disorder | Guidance - NICE — www.nice.org.uk — https://www.nice.org.uk/guidance/ng116
10. [PDF] PTSD (update) guideline - NICE — www.nice.org.uk — https://www.nice.org.uk/guidance/ng116/documents/consultation-comments-and-responses
11. [PDF] Post-traumatic stress disorder - NICE — www.nice.org.uk — https://www.nice.org.uk/guidance/ng116/evidence/evidence-review-i-organisation-and-delivery-of-care-for-people-with-ptsd-pdf-6602621013
12. Joint Clinical Practice Guideline on Benzodiazepine Tapering: Considerations When Risks Outweigh Benefits | Journal of General Internal Medicine | Springer Nature Link — www.ccjm.org — https://www.ccjm.org/lookup/external-ref?access_num=10.1007%2Fs11606-025-09499-2&link_type=DOI
13. The Posttraumatic Stress Disorder (PTSD) Checklist for DSM–5 - PMC — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC10292741
14. The Primary Care PTSD Screen for DSM-5 (PC-PTSD-5): Development and Evaluation Within a Veteran Primary Care Sample - PMC — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5023594
15. Evaluating the Performance of the Primary Care Posttraumatic ... — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC9885055
16. Exploring optimum cut-off scores to screen for probable posttraumatic stress disorder within a sample of UK treatment-seeking veterans - PMC — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC5800736
17. A comparison of the CAPS-5 and PCL-5 to assess PTSD in military and veteran treatment-seeking samples — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC10291904
18. Treatment Guidelines for PTSD: A Systematic Review - PMC — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471692?term=%22J+Clin+Med%22%5Bjour%5D
19. Evidence Brief: Psychedelic Medications for Mental Health and Substance Use Disorders - NCBI Bookshelf — www.ncbi.nlm.nih.gov — https://www.ncbi.nlm.nih.gov/books/NBK586533
20. Pragmatic Comparative Effectiveness of Primary Care Treatments for Posttraumatic Stress Disorder: A Randomized Clinical Trial. - Abstract — pubmed.ncbi.nlm.nih.gov — https://pubmed.ncbi.nlm.nih.gov/41091477
21. Management of trauma-related nightmares in PTSD: Can doxazosin ... — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S0013700626000333
22. Psychological interventions for adult posttraumatic stress disorder — www.sciencedirect.com — https://www.sciencedirect.com/science/article/pii/S0887618525000532
23. [PDF] Post-traumatic stress disorder: management (update) - NICE — www.nice.org.uk — https://www.nice.org.uk/guidance/ng116/documents/evidence-review-12
24. [PDF] Surveillance proposal consultation document | NICE — www.nice.org.uk — https://www.nice.org.uk/guidance/ph50/documents/surveillance-review-proposal

## Editorial note

Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.